Henderson EuroTrust

COVID-19: our performance, positioning and trading activity

By Jamie Ross Funds and Investment Trusts

13 mins. to read

It is too early to be overly confident, but we are gradually building confidence in the outlook for the market, writes Jamie Ross of Henderson EuroTrust. 

Novo Nordisk – the anatomy of a good company

By Jamie Ross Equities

7 mins. to read

Jamie Ross, fund manager of Henderson EuroTrust, explains the rationale behind the inclusion of the Danish pharmaceutical company Novo Nordisk in his portfolio.